Summary of Significant Accounting Policies (Details Textual) - USD ($)	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018	Jan. 02, 2019
Summary of Significant Accounting Policies (Textual)
Foreign currency translation gain	$ 467	$ 1,911
Restricted cash, description	The Company has restricted cash in connection with the patent and utility model infringement proceedings against TauroPharm (see Note 7). The Company was required by the District Court Mannheim to provide a security deposit of approximately €110,000 to cover legal fees in the event TauroPharm is entitled to reimbursement of these costs. The Company furthermore had to provide a deposit in the amount of €36,000 and €10,000 for the first and second instances, respectively, in connection with the unfair competition proceedings in Cologne.
Property and equipment	$ 126,820	160,860
Property and equipment accumulated depreciation	244,328	218,948
Deferred revenue recognized	$ 2,000	11,000
Deferred revenue, description	In August 2014, the Company entered into an exclusive distribution agreement (the “Wonik Agreement”) with Wonik Corporation, a South Korean company, to market, sell and distribute Neutrolin for hemodialysis and oncolytic patients upon receipt of regulatory approval in South Korea. Upon execution, Wonik paid the Company a non-refundable $50,000 payment and will pay an additional $50,000 upon receipt of the product registration necessary to sell Neutrolin in South Korea (the “Territory”).
Short-term leases term, description	Short-term leases are leases that have a term of 12 months or less and do not include an option to purchase the underlying asset that the Company is reasonably certain to exercise. The Company recognizes the lease payments for short-term leases on a straight-line basis over the lease term.
Operating lease, right-of-use asset			$ 6,000
New work order approximately	$ 1,400,000	1,400,000
Research and development expense - clinical and regulatory	1,500,000	$ 7,700,000
New work order approximately	27,400,000
Accured accounts payable	2,400,000
Cash payments	$ 3,000,000